Inventions Owned by Merck. Notwithstanding Section 10.1, the Parties agree that all rights to Inventions relating [*], are the exclusive property of Merck (“Merck Inventions”). Merck shall be entitled to file in its own name relevant patent applications and to own resultant patent rights for any Merck Invention. [*]
Appears in 3 contracts
Samples: Clinical Trial Collaboration and Supply Agreement (BioLineRx Ltd.), Clinical Trial Collaboration and Supply Agreement (BioLineRx Ltd.), Clinical Trial Collaboration and Supply Agreement (BioLineRx Ltd.)
Inventions Owned by Merck. Notwithstanding Section 10.110.1 (Joint Ownership and Prosecution), the Parties agree that all rights to Inventions relating [*], ** (“Merck *** Inventions”) are the exclusive property of Merck (“Merck Inventions”)Merck. Merck shall be entitled to file in its own name relevant patent applications and to own resultant patent rights for any such Merck *** Invention. [For the avoidance of doubt, any Invention *]**, even where the ***, is a Merck *** Invention and the exclusive property of Merck. Syndax shall and hereby does assign to Merck its entire right, title and interest in any such Merck *** Inventions.
Appears in 2 contracts
Samples: Clinical Trial Collaboration and Supply Agreement (Syndax Pharmaceuticals Inc), Clinical Trial Collaboration and Supply Agreement (Syndax Pharmaceuticals Inc)
Inventions Owned by Merck. Notwithstanding anything to the contrary contained in Section 10.1, the Parties agree that all rights to Inventions relating [*], ** are the exclusive property of Merck (“Merck Inventions”). Merck shall be entitled to file and prosecute in its own name relevant patent applications and to own resultant patent rights for any Merck Invention. [For the avoidance of doubt, any Invention *]** , even where the *** , is a Merck Invention. Adaptimmune hereby assigns its right, title and interest to any and all Merck Inventions to Merck.
Appears in 2 contracts
Samples: Clinical Trial Collaboration and Supply Agreement (Adaptimmune Therapeutics PLC), Clinical Trial Collaboration and Supply Agreement (Adaptimmune Therapeutics PLC)
Inventions Owned by Merck. Notwithstanding Section 10.1, the Parties agree that all rights to Inventions relating [*]solely to the Merck Compound, or a PD-1 Antagonist, are the exclusive property of Merck (“Merck Inventions”)Merck. Merck shall be entitled to file in its own name relevant patent applications and to own resultant patent rights for any Merck such Invention. [*]For the avoidance of doubt, any Invention generically encompassing the Merck Compound (and not the Advaxis Compound) within its scope, even where the Merck Compound is not disclosed per se, is the exclusive property of Merck.
Appears in 1 contract
Samples: Clinical Trial Collaboration and Supply Agreement (Advaxis, Inc.)
Inventions Owned by Merck. Notwithstanding anything to the contrary contained in Section 10.1, the Parties agree that all rights to Inventions relating solely to, or covering solely, the Merck Compound [*], **] are the exclusive property of Merck (“Merck Inventions”). Merck shall (a) be entitled to file and prosecute in its own name relevant patent applications Patent Applications in respect of Merck Inventions and to (b) own resultant patent rights for Patents that issue from any such Patent Applications in respect of Merck InventionInventions. [*]**] Rexahn hereby assigns its right, title and interest to any and all Merck Inventions to Merck.
Appears in 1 contract
Samples: Clinical Trial Collaboration and Supply Agreement (Rexahn Pharmaceuticals, Inc.)